Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Marco Y. W. Zaki"'
Autor:
Marco Y. W. Zaki, Ahmed M. Fathi, Samara Samir, Nardeen Eldafashi, Kerolis Y. William, Maiiada Hassan Nazmy, Moustafa Fathy, Upkar S. Gill, Shishir Shetty
Publikováno v:
Cancers, Vol 14, Iss 5, p 1255 (2022)
Viral hepatitis B (HBV) and hepatitis C (HCV) infections remain the most common risk factors for the development of hepatocellular carcinoma (HCC), and their heterogeneous distribution influences the global prevalence of this common type of liver can
Externí odkaz:
https://doaj.org/article/5097f3cd5eed44febf73c289eba5d320
Autor:
Nardeen Eldafashi, Rebecca Darlay, Ruchi Shukla, Misti Vanette McCain, Robyn Watson, Yang Lin Liu, Nikki McStraw, Moustafa Fathy, Michael Atef Fawzy, Marco Y. W. Zaki, Ann K. Daly, João P. Maurício, Alastair D. Burt, Beate Haugk, Heather J. Cordell, Cristiana Bianco, Jean-François Dufour, Luca Valenti, Quentin M. Anstee, Helen L. Reeves
Publikováno v:
Cancers, Vol 13, Iss 6, p 1412 (2021)
Obesity and non-alcoholic fatty liver disease (NAFLD) are contributing to the global rise in deaths from hepatocellular carcinoma (HCC). The pathogenesis of NAFLD-HCC is not well understood. The severity of hepatic steatosis, steatohepatitis and fibr
Externí odkaz:
https://doaj.org/article/ed778f0a70824f92bf6c77532b24072e
Autor:
Jack Leslie, Jill E. Hunter, Amy Collins, Amelia Rushton, Lauren G. Russell, Erik Ramon‐Gil, Maja Laszczewska, Misti McCain, Marco Y. W. Zaki, Amber Knox, Yixin Seow, Laura Sabater, Daniel Geh, Neil D. Perkins, Helen L. Reeves, Dina Tiniakos, Derek A. Mann, Fiona Oakley
Publikováno v:
Hepatology (Baltimore, Md.)REFERENCES.
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death. The NF-κB transcription factor family subunit c-Rel is typically protumorigenic; however, it has recently been reported as a tumor suppressor. Here, we investigated the role
Autor:
Piero Fariselli, Mohammed Eslam, Rocío Aller, Gian Paolo Caviglia, Anna Ludovica Fracanzani, Luca Miele, Manuel Romero-Gómez, Salvatore Petta, Ramy Younes, Chiara Rosso, Quentin M. Anstee, Jacob George, Elisabetta Bugianesi, Alastair D. Burt, Fabio Maria Vecchio, Rocío Gallego-Durán, María Jesús Pareja, Antonio Liguori, Javier Ampuero, Duncan McLeod, Grazia Pennisi, Antonio Grieco, Luca Valenti, Paolo Francione, Giovanni Birolo, Dina Tiniakos, Marco Maggioni, Ezio David, Angelo Armandi, Marco Y W Zaki, Daniela Cabibi, Olivier Govaere
Publikováno v:
Gut
Digital.CSIC. Repositorio Institucional del CSIC
instname
Digital.CSIC. Repositorio Institucional del CSIC
instname
[Objective] The full phenotypic expression of non-alcoholic fatty liver disease (NAFLD) in lean subjects is incompletely characterised. We aimed to investigate prevalence, characteristics and long-term prognosis of Caucasian lean subjects with NAFLD.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b819e7bd899fe8755c55e5d9aaf407f9
https://hdl.handle.net/10807/219753
https://hdl.handle.net/10807/219753
Autor:
Marco Y. W. Zaki, Ahmed M. Fathi, Samara Samir, Nardeen Eldafashi, Kerolis Y. William, Maiiada Hassan Nazmy, Moustafa Fathy, Upkar S. Gill, Shishir Shetty
Publikováno v:
Cancers. 14(5)
Viral hepatitis B (HBV) and hepatitis C (HCV) infections remain the most common risk factors for the development of hepatocellular carcinoma (HCC), and their heterogeneous distribution influences the global prevalence of this common type of liver can
Autor:
Marco Y W Zaki, Helen L. Reeves, Fiona Oakley, Shishir Shetty, Alex L Wilkinson, Daniel A. Patten
Publikováno v:
Journal of Visualized Experiments.
The aggressiveness and lack of well-tolerated and widely effective treatments for advanced hepatocellular carcinoma (HCC), the predominant form of liver cancer, rationalize its rank as the second most common cause of cancer-related death. Preclinical
Autor:
Caroline L. Wilson, Olivier Govaere, A. Whitehead, Ahmed Khairallah Mahdi, Jack Leslie, Sirintra Nakjang, Robyn Watson, G.L. Patman, Marco Y W Zaki, Charlotte Cox, Erik Ramon-Gil, João Maurício, John Lunec, Sameh Abou-Beih, Fiona Oakley, Quentin M. Anstee, Ruchi Shukla, Helen L. Reeves, Misti Vanette McCain, Derek A. Mann, Despina Televantou, Dina Tiniakos
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
The prevalence of obesity and non-alcoholic fatty liver disease (NAFLD) associated hepatocellular carcinoma (HCC) is rising, even in the absence of cirrhosis. We aimed to develop a murine model that would facilitate further understanding of NAFLD-HCC
Autor:
Gernot Schabbauer, Alona Agirre-Lizaso, Ana Landa, Pedro Rodrigues, Sylvia Knapp, Omar Sharif, Patricia Munoz-Garrido, Colm J O'Rourke, Mikel Azkargorta, Patricia Aspichueta, Jesper B. Andersen, Adelaida La Casta, Derek A. Mann, Marco Y W Zaki, Aitor Esparza-Baquer, Ekaterina Zhuravleva, Raul Jimenez-Agüero, Elizabeth Hijona, Fiona Oakley, Felix Elortza, Jesus M. Banales, Ibone Labiano, Luis Bujanda, Maria J. Perugorria, Andrea Vogel, Ioana Riaño
Publikováno v:
Addi: Archivo Digital para la Docencia y la Investigación
Universidad del País Vasco
Addi. Archivo Digital para la Docencia y la Investigación
instname
Esparza-Baquer, A, Labiano, I, Sharif, O, Agirre-Lizaso, A, Oakley, F, Rodrigues, P M, Zhuravleva, E, O'Rourke, C J, Hijona, E, Jimenez-Agüero, R, Riaño, I, Landa, A, La Casta, A, Zaki, M Y W, Munoz-Garrido, P, Azkargorta, M, Elortza, F, Vogel, A, Schabbauer, G, Aspichueta, P, Andersen, J B, Knapp, S, Mann, D A, Bujanda, L, Banales, J M & Perugorria, M J 2020, ' TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms ', Gut, vol. 70, no. 7 . https://doi.org/10.1136/gutjnl-2019-319227
Universidad del País Vasco
Addi. Archivo Digital para la Docencia y la Investigación
instname
Esparza-Baquer, A, Labiano, I, Sharif, O, Agirre-Lizaso, A, Oakley, F, Rodrigues, P M, Zhuravleva, E, O'Rourke, C J, Hijona, E, Jimenez-Agüero, R, Riaño, I, Landa, A, La Casta, A, Zaki, M Y W, Munoz-Garrido, P, Azkargorta, M, Elortza, F, Vogel, A, Schabbauer, G, Aspichueta, P, Andersen, J B, Knapp, S, Mann, D A, Bujanda, L, Banales, J M & Perugorria, M J 2020, ' TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms ', Gut, vol. 70, no. 7 . https://doi.org/10.1136/gutjnl-2019-319227
[EN] Objective Hepatocellular carcinoma (HCC) is a prevalent and aggressive cancer usually arising on a background of chronic liver injury involving inflammatory and hepatic regenerative processes. The triggering receptor expressed on myeloid cells 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5101dbc9d21276c380d697790fd43d3c
http://hdl.handle.net/10810/52822
http://hdl.handle.net/10810/52822
Autor:
Ben S. Barksby, Gabriele Spoletini, Marco Y W Zaki, Derek Manas, Jeremy French, Helen Brown, Abigail Watson, Lee A. Borthwick, Jack Leslie, Lee H. Reed, Mark C. Bryan, Julia C. Whitehall, Clive Griffiths, Michael Drinnan, Fiona Oakley, Marina García Macia, Stuart Robinson, Hannah L Paish, Laura C. Greaves, Steven A. White, Olivier Govaere, Xin Xu, Derek A. Mann, Jelena Mann
Publikováno v:
Hepatology (Baltimore, Md.)
Precision cut liver slices (PCLSs) retain the structure and cellular composition of the native liver and represent an improved system to study liver fibrosis compared to two-dimensional mono- or co-cultures. The aim of this study was to develop a bio
Autor:
Maria Jose Garcia Blanco, Piero Fariselli, Dina Tiniakos, Antonio Grieco, Chiara Rosso, Daniela Cabibi, Anna Ludovica Fracanzani, Fabio Maria Vecchio, Tiziana Sanavia, Javier Ampuero, Angelo Armandi, Olivier Govaere, Alastair D. Burt, Rocío Aller, Manuel Romero-Gómez, Elisabetta Bugianesi, Salvatore Petta, Antonio Liguori, Luca Miele, Gian Paolo Caviglia, Marco Maggioni, Luca Valenti, Ezio David, Paolo Francione, Rocío Gallego-Durán, María Jesús Pareja, Quentin M. Anstee, Marco Y W Zaki, Ramy Younes, Grazia Pennisi
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
[Background & Aims] Non-invasive scoring systems (NSS) are used to identify patients with non-alcoholic fatty liver disease (NAFLD) who are at risk of advanced fibrosis, but their reliability in predicting long-term outcomes for hepatic/extrahepatic